B Gulpers1, A Lugtenburg2, M Zuidersma2, F R J Verhey3, R C Oude Voshaar2. 1. VIRENZE-RIAGG Maastricht, METggz Maastricht, Regional Institute for Mental Health Care in Outpatients, Maastricht, The Netherlands; Maastricht University Medical Center, School for Mental Health and Neuroscience (MHeNS) / Alzheimer Centre Limburg and Department of Psychiatry and Psychology / MUMC, Maastricht, The Netherlands. Electronic address: bgulpers.uop@gmail.com. 2. University of Groningen, University Medical Center Groningen, Center for Psychiatry & Interdisciplinary Center of Psychopathology of Emotion regulation (ICPE), Groningen, The Netherlands. 3. Maastricht University Medical Center, School for Mental Health and Neuroscience (MHeNS) / Alzheimer Centre Limburg and Department of Psychiatry and Psychology / MUMC, Maastricht, The Netherlands.
Abstract
BACKGROUND: Anxiety possibly interferes with executive functioning, although most studies rely on anxiety symptoms or lack control for comorbid depression. The objective of the present study is to examine the association between executive functioning and (individual) anxiety disorders with ak,ld without controlling for depression. METHOD: Generalized anxiety disorder (GAD), panic disorder with and without agoraphobia, agoraphobia, social phobia, as well as depressive disorder according to DSM-IV criteria were assessed with the Mini International Neuropsychiatric Interview in 82,360 community-dwelling people participating in the Lifelines cohort. Figural fluency as a measure of executive functioning was assessed with the Ruff Figural Fluency Test (RFTT). Linear regression analyses with the RFFT score as the dependent variable and psychiatric diagnosis as independent variables (dummies) were performed, adjusted for potential confounders. Multivariate results are presented with and without adjustment for depression. RESULTS: Presence of any anxiety disorder was associated with worse performance on the RFFT (B = - 0.78, SE = 0.32, p = .015), independent of depression. No dose-response relationship with the number of anxiety disorders was found. Only agoraphobia and generalized anxiety disorder were significantly associated with the RFFT score in the multivariate models. Agoraphobia remained significant when further adjusted for depressive disorder (B = - 1.14, SE = 0.41, p < .01), while GAD did not (B = 0.013, SE = 0.431, p = .975). LIMITATIONS: Executive function was tested by only one measure, namely figural fluency. CONCLUSION: Agoraphobia is associated with worse executive functioning. Treatment of agoraphobia could be influenced by the executive dysfunction which clinicians should be aware of when regular treatment fails.
BACKGROUND:Anxiety possibly interferes with executive functioning, although most studies rely on anxiety symptoms or lack control for comorbid depression. The objective of the present study is to examine the association between executive functioning and (individual) anxiety disorders with ak,ld without controlling for depression. METHOD: Generalized anxiety disorder (GAD), panic disorder with and without agoraphobia, agoraphobia, social phobia, as well as depressive disorder according to DSM-IV criteria were assessed with the Mini International Neuropsychiatric Interview in 82,360 community-dwelling people participating in the Lifelines cohort. Figural fluency as a measure of executive functioning was assessed with the Ruff Figural Fluency Test (RFTT). Linear regression analyses with the RFFT score as the dependent variable and psychiatric diagnosis as independent variables (dummies) were performed, adjusted for potential confounders. Multivariate results are presented with and without adjustment for depression. RESULTS: Presence of any anxiety disorder was associated with worse performance on the RFFT (B = - 0.78, SE = 0.32, p = .015), independent of depression. No dose-response relationship with the number of anxiety disorders was found. Only agoraphobia and generalized anxiety disorder were significantly associated with the RFFT score in the multivariate models. Agoraphobia remained significant when further adjusted for depressive disorder (B = - 1.14, SE = 0.41, p < .01), while GAD did not (B = 0.013, SE = 0.431, p = .975). LIMITATIONS: Executive function was tested by only one measure, namely figural fluency. CONCLUSION:Agoraphobia is associated with worse executive functioning. Treatment of agoraphobia could be influenced by the executive dysfunction which clinicians should be aware of when regular treatment fails.
Authors: Mesut Savas; Christiaan H Vinkers; Judith G M Rosmalen; Catharina A Hartman; Vincent L Wester; Erica L T van den Akker; Anand M Iyer; Bruce S McEwen; Elisabeth F C van Rossum Journal: Neuroendocrinology Date: 2019-06-21 Impact factor: 4.914
Authors: Naoise Mac Giollabhui; Lauren B Alloy; Lizanne J S Schweren; Catharina A Hartman Journal: Brain Behav Immun Date: 2021-05-27 Impact factor: 19.227
Authors: Jenny Nyberg; Malin Henriksson; Alexander Wall; Torbjörn Vestberg; Maria Westerlund; Marion Walser; Robert Eggertsen; Louise Danielsson; H Georg Kuhn; N David Åberg; Margda Waern; Maria Åberg Journal: BMC Psychiatry Date: 2021-12-09 Impact factor: 3.630
Authors: George Savulich; Frank H Hezemans; Sophia van Ghesel Grothe; Jessica Dafflon; Norah Schulten; Annette B Brühl; Barbara J Sahakian; Trevor W Robbins Journal: Transl Psychiatry Date: 2019-11-12 Impact factor: 6.222